CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 183 filers reported holding CARA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $42,516 | -67.0% | 8,659 | -27.7% | 0.02% | -65.7% |
| Q4 2022 | $128,687 | +2.9% | 11,982 | -10.5% | 0.07% | +34.0% |
| Q3 2022 | $125,000 | +3.3% | 13,395 | +0.8% | 0.05% | +11.1% |
| Q2 2022 | $121,000 | -22.9% | 13,295 | +2.8% | 0.04% | -35.7% |
| Q1 2022 | $157,000 | -6.0% | 12,928 | -5.6% | 0.07% | +11.1% |
| Q4 2021 | $167,000 | -27.1% | 13,699 | -7.4% | 0.06% | -37.6% |
| Q3 2021 | $229,000 | +3.2% | 14,798 | -5.0% | 0.10% | +11.0% |
| Q2 2021 | $222,000 | -49.2% | 15,577 | -22.7% | 0.09% | -50.8% |
| Q1 2021 | $437,000 | +45.7% | 20,145 | +1.7% | 0.18% | +48.0% |
| Q4 2020 | $300,000 | +14.9% | 19,799 | -3.3% | 0.12% | -8.8% |
| Q3 2020 | $261,000 | -34.4% | 20,478 | -12.0% | 0.14% | -27.1% |
| Q2 2020 | $398,000 | +38.7% | 23,281 | +7.3% | 0.19% | +59.3% |
| Q1 2020 | $287,000 | -28.4% | 21,704 | -12.7% | 0.12% | +78.8% |
| Q4 2019 | $401,000 | +68.5% | 24,870 | +90.6% | 0.07% | +37.5% |
| Q3 2019 | $238,000 | -19.6% | 13,046 | -5.3% | 0.05% | -22.6% |
| Q2 2019 | $296,000 | +6.5% | 13,773 | -35.6% | 0.06% | +29.2% |
| Q4 2018 | $278,000 | -58.9% | 21,373 | -24.3% | 0.05% | -31.4% |
| Q3 2018 | $676,000 | -27.1% | 28,233 | -41.7% | 0.07% | -91.5% |
| Q2 2018 | $927,000 | +26.1% | 48,423 | -18.4% | 0.82% | +28.5% |
| Q1 2018 | $735,000 | +117.5% | 59,376 | +114.9% | 0.64% | +50.5% |
| Q4 2017 | $338,000 | +30.5% | 27,635 | +46.1% | 0.42% | +1111.4% |
| Q3 2017 | $259,000 | -1.9% | 18,915 | +10.1% | 0.04% | -10.3% |
| Q2 2017 | $264,000 | -55.7% | 17,185 | -47.0% | 0.04% | -63.2% |
| Q1 2017 | $596,000 | +119.1% | 32,394 | +10.6% | 0.11% | +30.9% |
| Q4 2016 | $272,000 | +169.3% | 29,288 | +80.0% | 0.08% | -41.7% |
| Q1 2016 | $101,000 | -65.4% | 16,267 | -6.0% | 0.14% | -82.6% |
| Q4 2015 | $292,000 | – | 17,299 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |